353 related articles for article (PubMed ID: 18655096)
1. Helminth infections associated with multiple sclerosis induce regulatory B cells.
Correale J; Farez M; Razzitte G
Ann Neurol; 2008 Aug; 64(2):187-99. PubMed ID: 18655096
[TBL] [Abstract][Full Text] [Related]
2. Regulatory B cells, helminths, and multiple sclerosis.
Correale J; Equiza TR
Methods Mol Biol; 2014; 1190():257-69. PubMed ID: 25015286
[TBL] [Abstract][Full Text] [Related]
3. Helminth antigens modulate immune responses in cells from multiple sclerosis patients through TLR2-dependent mechanisms.
Correale J; Farez M
J Immunol; 2009 Nov; 183(9):5999-6012. PubMed ID: 19812189
[TBL] [Abstract][Full Text] [Related]
4. The impact of parasite infections on the course of multiple sclerosis.
Correale J; Farez MF
J Neuroimmunol; 2011 Apr; 233(1-2):6-11. PubMed ID: 21277637
[TBL] [Abstract][Full Text] [Related]
5. A Trypanosoma cruzi antigen signals CD11b+ cells to secrete cytokines that promote polyclonal B cell proliferation and differentiation into antibody-secreting cells.
Montes CL; Acosta-Rodríguez EV; Mucci J; Zuniga EI; Campetella O; Gruppi A
Eur J Immunol; 2006 Jun; 36(6):1474-85. PubMed ID: 16688679
[TBL] [Abstract][Full Text] [Related]
6. Multiple sclerosis: reduced proportion of circulating plasmacytoid dendritic cells expressing BDCA-2 and BDCA-4 and reduced production of IL-6 and IL-10 in response to herpes simplex virus type 1.
Sanna A; Huang YM; Arru G; Fois ML; Link H; Rosati G; Sotgiu S
Mult Scler; 2008 Nov; 14(9):1199-207. PubMed ID: 18653740
[TBL] [Abstract][Full Text] [Related]
7. Interferon-beta regulates cytokines and BDNF: greater effect in relapsing than in progressive multiple sclerosis.
Hamamcioglu K; Reder AT
Mult Scler; 2007 May; 13(4):459-70. PubMed ID: 17463069
[TBL] [Abstract][Full Text] [Related]
8. Novel function of B cell-activating factor in the induction of IL-10-producing regulatory B cells.
Yang M; Sun L; Wang S; Ko KH; Xu H; Zheng BJ; Cao X; Lu L
J Immunol; 2010 Apr; 184(7):3321-5. PubMed ID: 20208006
[TBL] [Abstract][Full Text] [Related]
9. Increase in multiple sclerosis activity after assisted reproduction technology.
Correale J; Farez MF; Ysrraelit MC
Ann Neurol; 2012 Nov; 72(5):682-94. PubMed ID: 23034952
[TBL] [Abstract][Full Text] [Related]
10. Memory and naïve B-cell subsets in patients with multiple sclerosis.
Niino M; Hirotani M; Miyazaki Y; Sasaki H
Neurosci Lett; 2009 Oct; 464(1):74-8. PubMed ID: 19666086
[TBL] [Abstract][Full Text] [Related]
11. B cell expression of the inhibitory Fc gamma receptor is unchanged in early MS.
Comabella M; Montalban X; Kakalacheva K; Osman D; Nimmerjahn F; Tintoré M; Lünemann JD
J Neuroimmunol; 2010 Jun; 223(1-2):135-7. PubMed ID: 20399509
[TBL] [Abstract][Full Text] [Related]
12. Immunological mechanisms that associate with oligoclonal IgM band synthesis in multiple sclerosis.
Villar LM; Espiño M; Cavanillas ML; Roldán E; Urcelay E; de la Concha EG; Sádaba MC; Arroyo R; González-Porqué P; Alvarez-Cermeño JC
Clin Immunol; 2010 Oct; 137(1):51-9. PubMed ID: 20621566
[TBL] [Abstract][Full Text] [Related]
13. Tr1 and naturally occurring regulatory T cells induce IgG4 in B cells through GITR/GITR-L interaction, IL-10 and TGF-beta.
Satoguina JS; Adjobimey T; Arndts K; Hoch J; Oldenburg J; Layland LE; Hoerauf A
Eur J Immunol; 2008 Nov; 38(11):3101-13. PubMed ID: 18924213
[TBL] [Abstract][Full Text] [Related]
14. Regulation of IL-13 receptor alpha 1 expression and signaling on human tonsillar B-lymphocyte subsets.
Hajoui O; Zheng H; Guay J; Letuve S; Fawaz LM; Mazer BD
J Allergy Clin Immunol; 2007 Dec; 120(6):1425-32. PubMed ID: 17761275
[TBL] [Abstract][Full Text] [Related]
15. Low and dysregulated BDNF secretion from immune cells of MS patients is related to reduced neuroprotection.
Azoulay D; Urshansky N; Karni A
J Neuroimmunol; 2008 Mar; 195(1-2):186-93. PubMed ID: 18329726
[TBL] [Abstract][Full Text] [Related]
16. Production of brain-derived neurotrophic factor by mononuclear cells of patients with multiple sclerosis treated with glatiramer acetate, interferon-beta 1a, and high doses of immunoglobulins.
Sarchielli P; Zaffaroni M; Floridi A; Greco L; Candeliere A; Mattioni A; Tenaglia S; Di Filippo M; Calabresi P
Mult Scler; 2007 Apr; 13(3):313-31. PubMed ID: 17439900
[TBL] [Abstract][Full Text] [Related]
17. IL-10 suppressor activity and ex vivo Tr1 cell function are impaired in multiple sclerosis.
Martinez-Forero I; Garcia-Munoz R; Martinez-Pasamar S; Inoges S; Lopez-Diaz de Cerio A; Palacios R; Sepulcre J; Moreno B; Gonzalez Z; Fernandez-Diez B; Melero I; Bendandi M; Villoslada P
Eur J Immunol; 2008 Feb; 38(2):576-86. PubMed ID: 18200504
[TBL] [Abstract][Full Text] [Related]
18. Secretory products of multiple sclerosis B cells are cytotoxic to oligodendroglia in vitro.
Lisak RP; Benjamins JA; Nedelkoska L; Barger JL; Ragheb S; Fan B; Ouamara N; Johnson TA; Rajasekharan S; Bar-Or A
J Neuroimmunol; 2012 May; 246(1-2):85-95. PubMed ID: 22458983
[TBL] [Abstract][Full Text] [Related]
19. Impact of myelin-specific antigen presenting B cells on T cell activation in multiple sclerosis.
Harp CT; Lovett-Racke AE; Racke MK; Frohman EM; Monson NL
Clin Immunol; 2008 Sep; 128(3):382-91. PubMed ID: 18599355
[TBL] [Abstract][Full Text] [Related]
20. The role of helper and regulatory T cells in the pathogenesis of vitiligo.
Basak PY; Adiloglu AK; Ceyhan AM; Tas T; Akkaya VB
J Am Acad Dermatol; 2009 Feb; 60(2):256-60. PubMed ID: 19022528
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
